Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$155.44M
Total Bought:
$19.20M
Total Sold:
$11.37M
Net Transaction:
+$7.83M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Aclaris Therapeutics, Inc.(ACRS)14,250,00014,250,0000$42.89M$53.44M34.38%+$10.54M
Atea Pharmaceuticals, Inc.(AVIR)7,490,0007,058,657-431,343$26.74M$37.98M24.43%+$11.24M
Oramed Pharmaceuticals Inc.(ORMP)3,167,2313,167,2310$9.03M$10.77M6.93%+$1.74M
Tilly's, Inc.CL A(TLYS)02,150,000+2,150,000$0$8.71M5.60%+$8.71M
Outset Medical, Inc.(OM)543,1801,902,201+1,359,021$2.02M$7.30M4.70%+$5.29M
PMV Pharmaceuticals, Inc.(PMVP)5,292,0005,320,000+28,000$6.62M$6.60M4.24%-$18.2K
CarMax, Inc.(KMX)155,000155,0000$5.99M$6.44M4.15%+$455.7K
Kezar Life Sciences Inc
COM NEW
720,787720,7870$4.53M$5.35M3.44%+$814.5K
Instil Bio, Inc.(TIL)645,600645,6000$7.10M$5.32M3.42%-$1.78M
Target Corporation(TGT)37,50037,5000$3.67M$4.54M2.92%+$879.4K
The Kraft Heinz Company(KHC)0125,000+125,000$0$2.81M1.81%+$2.81M
Janux Therapeutics, Inc.(JANX)0154,961+154,961$0$2.15M1.39%+$2.15M
Pliant Therapeutics, Inc.(PLRX)1,546,1371,546,1370$1.89M$1.95M1.25%+$61.8K
Connect Biopharma Holdings LimitedSHS(CNTB)408,887408,8870$1.15M$1.07M0.69%-$81.8K
ImageneBio, Inc.(IMA)177,026200,730+23,704$1.22M$1.00M0.65%-$217.8K
Lisata Therapeutics, Inc.(LSTA)73,3480-73,348$136.4K$0—-$136.4K
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q1 2026 | TickerTrail